Boost your business with an innovative inhaler partner
Development of inhalation products
The development of inhalation products is very complex and therefore seen as time consuming and associated with a high risk. The interaction between user requirements, performance and regulatory and manufacturing requirements, proofs to be too challenging for most pharmaceutical companies. The market for inhaled pharmaceuticals presents a great business opportunity and there are new therapeutic areas for inhaled therapy, for example vaccination and allergy.
The market for inhaled pharmaceuticals presents a great business opportunity and there are new therapeutic areas for inhaled therapy, for example vaccination and allergy.
Collaboration with Iconovo will give the customer a unique inhaler product at reduced project risk. Iconovo has significant experience and expertise in developing inhaler products together with innovative pharmaceutical companies.
Shorter time to market with a customized inhaler platform
In the next few years, the patents will expire for many best-selling inhaled medicines. For generic inhalation products, you need a new inhaler that does not infringe on the original manufacturer’s patent, and that you formulate the drug substances so that they work together with the new inhaler. The time to first clinical study is critical and the manufacture of clinical study material must be quick and smooth.
Reduce development risk with the right expertise
Inhalation is often used to treat conditions in the respiratory system and the lungs, for example COPD or asthma. The interaction between the pharmaceutical and the inhaler device is complex and requires both formulation and design expertise. Iconovo has significant experience and expertise in developing inhaler products together with innovative pharmaceutical companies.
Bring inhalation expertise to your business
Both originator and generic drug companies can benefit from proprietary inhaler platforms and formulation development expertise. By partnering with Iconovo, companies do not have to build up in-house product development expertise, reducing costs and shortening lead times to market launches of their products. Iconovo inhalers are equally well suited for brand new types of drugs as for generic products.